I. Wilding

发表

The role of gamma-scintigraphy in oral drug delivery.

I. Wilding, A. Coupe, S. Davis, 2001, Advanced drug delivery reviews.

The role of γ-scintigraphy in oral drug delivery

I. Wilding, A. Coupe, S. Davis, 1991 .

An analysis of the surface chemical structure of polymethacrylate (Eudragit) film coating polymers by XPS

M. Davies, I. Wilding, J. Watts, 1989 .

Enteric coated HPMC capsules designed to achieve intestinal targeting.

I. Wilding, A. Connor, H. Petereit, 2002, International journal of pharmaceutics.

Remote controlled capsules in human drug absorption (HDA) studies.

David V. Prior, I. Wilding, 2003, Critical reviews in therapeutic drug carrier systems.

Assessment of Lumiracoxib Bioavailability from Targeted Sites in the Human Intestine Using Remotely Activated Capsules and Gamma Scintigraphy

I. Wilding, A. Connor, C. Rordorf, 2004, Pharmaceutical Research.

Site-specific drug delivery in the gastrointestinal tract.

I. Wilding, 2000, Critical reviews in therapeutic drug carrier systems.

The assessment of human regional drug absorption of free acid and sodium salt forms of Acipimox, in healthy volunteers, to direct modified release formulation strategy

I. Wilding, A. Connor, Heather Wray, 2009, Biopharmaceutics & drug disposition.

A scintigraphic study to investigate the potential for altered gut distribution of loperamide from a loperamide-simethicone formulation in man.

I. Wilding, A. Connor, A L Connor, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Gamma scintigraphy : an in vivo technique for assessing the equivalence of inhaled products

I. Wilding, S. Newman, 1998 .

Optimizing gastrointestinal delivery of drugs.

I. Wilding, S. Davis, D. O'hagan, 1994, Bailliere's clinical gastroenterology.

Gastrointestinal transit of a matrix tablet formulation : comparison of canine and human data

I. Wilding, S. Davis, E. Wilding, 1993 .

The in-situ chemical analysis of polymer film coatings using static secondary ion mass spectrometry (SSIMS)

M. Davies, R. Rowe, I. Wilding, 1990 .

The effect of mannitol on the oral bioavailability of cimetidine.

I. Wilding, S. Davis, R. A. Sparrow, 1995, Journal of pharmaceutical sciences.

SSIMS analysis of methacrylate copolymers employed in drug delivery

M. Davies, I. Wilding, R. Short, 1990 .

The Effect of Oleic Acid on the Human Ileal Brake and Its Implications for Small Intestinal Transit of Tablet Formulations

I. Wilding, S. Davis, R. A. Sparrow, 2004, Pharmaceutical Research.

The effect of ileal brake activators on the oral bioavailability of atenolol in man.

I. Wilding, S. Davis, R. A. Sparrow, 2002, International journal of pharmaceutics.

Does the site of intestinal delivery of oleic acid alter the ileal brake response?

I. Wilding, S. Davis, R. A. Sparrow, 2000, International journal of pharmaceutics.

Is the pig a good animal model for studying the human ileal brake?

I. Wilding, S. Davis, M. Hinchcliffe, 1998, Journal of pharmaceutical sciences.

Localization of Drug Release Sites from an Oral Sustained‐Release Formulation of 5‐ASA (Pentasa®) in the Gastrointestinal Tract Using Gamma Scintigraphy

I. Wilding, J. Hardy, R. A. Sparrow, 1993, Journal of clinical pharmacology.

The Effect of Meal Composition on the Gastrocolonic Response: Implications for Drug Delivery to the Colon

I. Wilding, S. Davis, R. A. Sparrow, 1993, Pharmaceutical Research.

Gastrointestinal Transit and Systemic Absorption of Captopril from a Pulsed-Release Formulation

I. Wilding, S. Davis, H. Stevens, 1992, Pharmaceutical Research.

Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation

I. Wilding, G. Hooper, D. Friend, 1997, Alimentary pharmacology & therapeutics.

A comparison of the gastric retention of a sucralfate gel and a sucralfate suspension

I. Wilding, G. Hooper, J. Hardy, 1993 .

A novel multiunit controlled-release system

I. Wilding, J. Devane, John Brown, 1998 .

Spreading and Retention of Vaginal Formulations in Post-Menopausal Women as Assessed by Gamma Scintigraphy

J. Humphries, I. Wilding, S. Davis, 1997, Pharmaceutical Research.

Evaluation of 153Sm-diethylenetriaminepentaacetic acid for radiolabelling of pharmaceutical dosage forms by neutron activation.

I. Wilding, S. Davis, S. Parry, 1994, Nuclear medicine and biology.

Intestinal Performance of Two Mesalamine Formulations in Patients with Active Ulcerative Colitis as Assessed by Gamma Scintigraphy

I. Wilding, A. Connor, D. J. Ball, 2003 .

The Use of Pharmacoscintigraphy to Elucidate Food Effects Observed with a Novel Protease Inhibitor (Saquinavir)

G. McClelland, I. Wilding, C. Kenyon, 1998, Pharmaceutical Research.

Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon.

R. Anziano, I. Wilding, B. Henry, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

In Vitro and in Vivo Pharmacoscintigraphic Evaluation of Ibuprofen Hypromellose and Gelatin Capsules

I. Wilding, A. Connor, E. Cole, 2004, Pharmaceutical Research.

The Use of Scintigraphy to Provide 'Proof of Concept' for Novel Polysaccharide Preparations Designed for Colonic Drug Delivery

I. Wilding, A. Rubinstein, I. Landau, 2004, Pharmaceutical Research.

The use of pharmacoscintigraphy to focus the development strategy for a novel 5-ASA colon targeting system (TIME CLOCK® system)

I. Wilding, G. Hooper, M. Benedetti, 1997 .

The time clock system: a new oral dosage form for fast and complete release of drug after a predetermined lag time☆

I. Wilding, S. Davis, A. Gazzaniga, 1994 .

Targeting of drugs and vaccines to the gut.

I. Wilding, S. Davis, D. O’hagan, 1994, Pharmacology & therapeutics.

Systemic Availability of the Active Metabolite Hydroxy‐Fasudil After Administration of Fasudil to Different Sites of the Human Gastrointestinal Tract

I. Wilding, A. Karara, P. Hinderling, 2007, Journal of clinical pharmacology.

The role of gastric emptying in the absorption and metabolism of nifedipine given in a modified release pellet formulation

I. Wilding, S. Davis, R. A. Sparrow, 1992 .

Effect of altered gastric emptying and gastrointestinal motility on metformin absorption.

I. Wilding, P. Marathe, R. Barbhaiya, 2000, British journal of clinical pharmacology.

A Simple and Rapid Method for the Quantification of Eudragit RS100 and RL100 Poly(methacrylates) in Sustained-Release Dosage Forms

K. A. Khan, I. Wilding, C. Melia, 1991, Pharmaceutical Research.

Variation in Gastrointestinal Transit of Pharmaceutical Dosage Forms in Healthy Subjects

I. Wilding, A. Coupe, S. Davis, 1991, Pharmaceutical Research.

Scintigraphic evaluation of a novel colon-targeted delivery system (CODES) in healthy volunteers.

Yoshinori Masuda, Muneo Fukui, Katsutoshi Nakamura, 2004, Journal of pharmaceutical sciences.

Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers.

I. Wilding, S. Davis, J. Hardy, 1991, British journal of clinical pharmacology.

The Effect of Cross-Linking on the In Vivo Disintegration of Hard Gelatin Capsules

I. Wilding, E. Cole, D. Cadé, 1998, Pharmaceutical Research.

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes

M. Horowitz, I. Wilding, M. Nauck, 2008, Regulatory Peptides.

Gastrointestinal transit of a multiparticulate tablet formulation in patients with active ulcerative colitis

I. Wilding, C. Robertson, S. Davis, 1991 .

Development of oral extended release formulations of 6‐hydroxybuspirone

Jianing Zeng, Peter Ferrie, Peter Timmins, 2012, Biopharmaceutics & drug disposition.

The in vivo behaviour of a colonic delivery system: a pilot study in man

I. Wilding, P. Ventura, G. Hooper, 1994 .

Colonic spread of three rectally administered mesalazine (Pentasa) dosage forms in healthy volunteers as assessed by gamma scintigraphy

I. Wilding, S. Haines, J. Brown, 1997, Alimentary pharmacology & therapeutics.

Bioequivalence Testing for Locally Acting Gastrointestinal Products: What Role for Gamma Scintigraphy?

I. Wilding, 2002, Journal of clinical pharmacology.

Colonic spreading of a non‐chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis

I. Wilding, G. Hooper, H. Staab, 1995, Alimentary Pharmacology and Therapeutics.

The effects of pharmaceutical excipients on small intestinal transit.

I. Wilding, S. Davis, R. A. Sparrow, 1995, British journal of clinical pharmacology.

Gamma scintigraphy in the evaluation of pharmaceutical dosage forms

I. Wilding, S. Davis, S. Newman, 2004, European Journal of Nuclear Medicine.

Assessment of Nevirapine Bioavailability From Targeted Sites in the Human Gastrointestinal Tract

T. Macgregor, I. Wilding, C. Yong, 2009, Journal of clinical pharmacology.

Evolution of the biopharmaceutics classification system (BCS) to oral modified release (MR) formulations; what do we need to consider?

I. Wilding, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Scintigraphic and pharmacokinetic assessment of a multiparticulate sustained release formulation of diltiazem

I. Wilding, S. Davis, J. Hardy, 1991 .

Colonic transit of different sized tablets in healthy subjects

I. Wilding, Stanley S. Davis, Dawn A. Adkin, 1993 .

The Gastrointestinal Transit and Systemic Absorption of Diltiazem HCL from a Modified Release Dosage Form

I. Wilding, D. Heald, J. Ziemniak, 1993 .

The Distribution of an Intranasal Insulin Formulation in Healthy Volunteers: Effect of Different Administration Techniques

I. Wilding, S. Newman, G. Hooper, 1994, The Journal of pharmacy and pharmacology.

Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study.

I. Wilding, A. Connor, N. Undre, 2014, Clinical therapeutics.

Human lung deposition data: the bridge between in vitro and clinical evaluations for inhaled drug products?

I. Wilding, S. Newman, S P Newman, 2000, International journal of pharmaceutics.

Oral drug absorption studies: the best model for man is man!

I. Wilding, S. Davis, 2001, Drug discovery today.

Enteric coated timed release systems for colonic targeting

I. Wilding, S. Davis, A. Gazzaniga, 1994 .

Visualization of Product Performance in the Gut: What Role in the Drug Development/Regulatory Paradigm?

I. Wilding, D. Heald, 1999, Journal of clinical pharmacology.

The effect of food on the in vivo behaviour of a novel sustained release formulation of tiaprofenic acid

I. Wilding, R. A. Sparrow, G. Hayes, 1992 .

Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR).

I. Wilding, S. Davis, C. Melia, 1991, Clinical neuropharmacology.

Deposition of a model substance, 99m Tc E-HIDA, in the oral cavity after administration of lozenges, chewing gum and sublingual tablets

I. Wilding, S. Davis, C. Melia, 1990 .

Development of a gastric retentive system as a sustained-release formulation of pranlukast hydrate and its subsequent in vivo verification in human studies.

Hirofumi Takeuchi, H. Takeuchi, I. Wilding, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

New developments in radionuclide imaging for assessing drug delivery in man.

I. Wilding, S. Newman, P. Hirst, 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pharmacoscintigraphic evaluation of a modified release (Geomatrix®) diltiazem formulation

I. Wilding, S. Davis, D. Heald, 1995 .

The effect of sleep on the gastrointestinal transit of pharmaceutical dosage forms

I. Wilding, A. Coupe, S. Davis, 1992 .

Do pellet formulations empty from the stomach with food

I. Wilding, A. Coupe, S. Davis, 1993 .

The effect of food on the gastrointestinal transit and systemic absorption of naproxen from a novel sustained release formulation

I. Wilding, J. Devane, G. Hooper, 1995 .

The effect of fibre on gastrointestinal transit times in vegetarians and omnivores

I. Wilding, S. Davis, J. Price, 1991 .

Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans.

A. Fujimura, I. Wilding, Shuji Sato, 2004, Journal of controlled release : official journal of the Controlled Release Society.